Tomorrow’s Medicine

Pediatric hematology-oncology research has come a long way so that 80% of children diagnosed with cancer can recover today. We must continue on this path.

That’s why the Foundation has committed in June 2021 to invest more than $25 million over five years in research to fight pediatric cancer in Quebec.

This announcement marks a milestone for Fondation Charles-Bruneau, not only for the magnitude of the investment, but also because the four pediatric oncology centres in Quebec will use their respective expertise and research teams to fight childhood cancer. The battle will be waged on all fronts: cell-by-cell analysis of cancer, simplification of diagnosis and follow-up, precision treatments (targeted therapy, cell and gene therapy), improved nursing care, screening and management of psychological distress (particularly through art therapy), and prevention of cancer’s after-effects through the promotion of healthy lifestyle habits.

The foundation’s vision and leadership will enable pediatric hemato-oncology researchers with the province’s four institutions to work together for the benefit of thousands of children and their families across Quebec.

Thanks to the research underway, tomorrow’s medicine is truly being practiced today.

Discover below the distribution of the commitment.

CHU Sainte-Justine

More than $11 million to support innovative research into cell-by-cell analysis of cancer and development of new treatments (targeted therapies, cellular and gene therapies). The support of Fondation Charles-Bruneau will also make it possible to deliver concrete results of previous research to patients: implementation of molecular diagnostics, support for families in psychological distress, and support for healthy lifestyle habits to reduce the risk of after-effects from cancer and its treatments.

CIUSSS de l’Estrie-CHUS

Close to $250,000 to support a pharmacist position dedicated to the development of the pediatric pharmacological research sector in the context of the CHUS's recent membership of the COG, and thus accelerate the opening of therapeutic studies. The support of Fondation Charles-Bruneau will also fund the acquisition of necessary material resources.

CHU de Québec-Université Laval

Nearly $9 million to implement a project to improve nursing support for children with cancer, in cooperation with the children and their families. This project will have an impact throughout Quebec and beyond. By adapting care to the needs of families, this research will heighten the expertise of nurses and facilitate their retention.